Prognosis of portal hypertension: Digestive system hemorrhage by esophageal varices rupture;PRONOSTIC DE L'HYPERTENSION PORTALE: HEMORRAGIE DIGESTIVE PAR RUPTURE DE VARICES OESOPHAGIENNES

Hepato-Gastro

Volumn 5, Issue 5, 1998, Pages 371-377

  Oberti, Frédéric ^a  

^a ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; NADOLOL; OCTREOTIDE; PROPRANOLOL; SCLEROSING AGENT; TERLIPRESSIN;

DIGESTIVE SYSTEM HEMORRHAGE; ESOPHAGUS VARICES; ESOPHAGUS VARICES BLEEDING; HUMAN; PRIMARY PREVENTION; PROGNOSIS; REVIEW; RUPTURE; SCLEROTHERAPY; SECONDARY PREVENTION;

EID: 0031658805     PISSN: 12537020     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (62)

1. Pagliaro L, d'Amico G, Luca G, Pasta L, Politi F, Aragona E, et al Portal hypertension : diagnosis and treatment. J Hepatol 1995 , 23 : 36-44.
2. D'Amico A, Luca A. Natural history. Clinical haemodynamic correlations. Prediction of the risk of bleeding. Baillière's Clin Gastroenterol 1997, 11 : 243-56.
3. Calès P. Hémorragies digestives des cirrhoses. Rev Prat 1997 , 47 : 497-502.
4. Lebrec D. Prévention primaire des hémorragies digestives de l'hypertension portale. Gastroentérol Clin Biol 1997 ; 21 391-3
5. Zoli M, Merkel C, Magalotti D, Marchesini G, Gatta A, Pisi E. Evaluation of a new endoscopie index to predict first bleeding from the upper gastrointestinal tract in patients with cirrhosis. Hepatology 1996 , 24 : 1047-52.
6. Le Moine O, Hadengue A, Moreau R, Sogni P, Soupison T, Yang S, et al Relationship between portal pressure, esophageal varices, and variceal bleeding on the basis of the stage and cause of cirrhosis. Scand J Gastroenterol 1997 ; 32 . 731-5.
7. Corrao G, Ferrari P, Zambon A, Torchio P, Arico S, Decarli A Trends of liver cirrhosis mortality in Europe, 1970-1989 : age period cohort analysis and changing alcohol consumption. Int J Epidemiol 1997 ; 26 : 100-9.
8. Armonis A, Patch D, Burroughs A. Hepatic venous pressure measurement : an old test as a new prognostic marker in cirrhosis. Hepatology 1997 , 25 : 245-8.
9. Vorobioff J, Groszmann R, Picabea E, Gamen M, Villavicencio R, Bordato J, et al. Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis : a 10 years prospective study. Gastroenterology 1996 , 111 . 701-9.
10. Colman J, Cromie S, Jones P, Dudley F Clinical relevance of sequential portal pressure measurements in alcoholic cirrhosis. Hepatology 1997 ; 26 . 207A (abstract).
11. Luca A, Garcia-Pagan JC, Bosch J, Feu F, Caballeria J, Groszmann R, et al. Effects of ethanol consumption on hepatic hemodydamics in patients with alcoholic cirrhosis. Gastroenterology 1997 ; 112 : 1284-9.
12. Nevens F, Van Roey G, Setijoso E, Fevery J The response of variceal pressure to pharmacotherapy is a predictor of the risk of variceal bleeding in cirrhotic patients Hepatology 1997 ; 26 : 135A (abstract)
13. Albillos A, Perez-Poramo M, Cacho G, Iborra J, Calleja JL, Millian I, et al. Accuracy of portal and forearm blood flow for measurement in the assessment of the portal pressure response to propranolol. J Hepatol 1997 , 27 : 496-504.
14. Leung V, Sung J, Ahuja A, Tumala I, Lee Y, Lau J, et al Large paraesophageal varices on endosonography predict recurrence of esophageal varices and rebleeding Gastroenterology 1997 , 112 : 1811-6.
15. Dhiman R, Choudhuri G, Saraswat V, Agarwal D, Naik S. Role of paraoesophageal collaterals and perforating veins on outcome of endoscopie sclerotheropy for oesophageal varices : an endosonographic study Gut 1996 , 38 : 759-64.
16. Escorsell A, Bordas J, Feu F, Garcia-Pagan JC, Gines A, Bosch J, et al. Endoscopic assessment of variceal volume and wall tension in cirrhotic patients . effects of pharmacological therapy. Gastroenterology 1997, 113 1640-6
17. Kassem A, Salama Z, Rösch T. Endoscopic ultrasonography in portal hypertension Endoscopy 1997 ; 29 : 399-406
18. Hartigan P, Gebhard R, Gregory P. Sclerotherapy for actively bleeding esophageal varices in male alcoholics with cirrhosis Gastroinrest Endosc 1997 ; 46 : 1-7.
19. Jenkins S, Shields R, Davies M, Elias E, Turnbull A, Bassendine M, et al A multicenter randomized trial comparing octreotide and injection sclerotherapy in the management and outcome of acute variceal haemorrhage. Gut 1997 ; 41 : 526-33.
20. Cooperative Spanish-French Group for the treatment of bleeding esophageal varices : randomized controlled trial comparing terlipressin vs endoscopic injection sclerotherapy in the treatment of acute variceal bleeding and prevention of early rebleeding. Hepatology 1997 , 26 : 249A (abstract)
21. Avqerinos A, Nevens F, Raptis S, Fevery J and the Above study group Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds : the European Acute Bleeding Oesophageal Variceal Episodes randomised trial Lancet 1997 ; 350 : 1495-9
22. Signorelli S, Paris B, Negrini F, Bonelli M, Auriemma L. Esophageal varices bleedings : comparison between treatment with sclerotherapy alone vs sclerotherapy plus octreotide. Hepatology 1997 ; 26 : 137A (abstract).
23. Harada T, Yoshido T, Shigemitsu T, Takeo Y, Tada M, Okita K. Therapeutic results of endoscopie variceal ligation for acute bleeding of oesophageal and gastric varices. J Gastroenterol Hepatol 1997 ; 12 : 331-5.
24. Lo GH, Lai KH, Cheng JS, Lin CK, Huang JS, Hsu PI. Emergency banding ligation versus sclerotherapy for the control of active bleeding from esophageal varices. Hepatology 1997 ; 25 . 1101-4.
25. Pauwels A, Mostefa-Kara N, Debenes B, Degoutte E, Levy VG. Systemic antibiotic prophylaxis after gastrointestinal hemorrhage in cirrhotic patients with a high risk of infection. Hepatology 1996 ; 24 : 802-6.
26. Sanyal A, Freedman A, Luketic V, Purdum P, Shiffman M, Tisnado J, et al. Transjugular, intrahepatic portosystemic shunts for patients with active variceal hemorrhage unresponsive to sclerotherapy. Gostroenterology 1996 ; 111 : 138-46.
27. Grozsmann RJ. β-adrenergic blockers and nitrovasodilators for the treatment of portal hypertension : the good, the bad, the ugly. Gastroenterology 1997 , 113 : 1794-7.
28. Angelico M, Carli L, Piat C, Gentile S, Capocaccia L. Effects of isosorbide-5-mononitrate compared with propranolol on first bleeding and long-term survival in cirrhosis. Gastroenterology 1997, 113 : 1632-9.
29. Zoli M, Magalotti D, Ghigi G, Marchesini G, Pisi E. Transdermal nitroglycerin in cirrhosis. A 24-hour echo-Doppler study of splanchnic hemodynamics. J Hepatol 1996 ; 25 : 498-503.
30. Merkel C, Sacerdoti D, Bolognesi M, Enzo E, Marin R, Bombonato G, et al. Hemodynamic evaluation of the addition of isosorbide-5-mononitrate to nadolol in cirrhotic patients with insufficient response to the β-blocker alone. Hepatology 1997 ; 26 . 34-9.
31. Abecasis R, Kravetz D, Fassion E, Ameigeiras B, Garcia D, Isla R, et al. Nadolol plus spironolactone versus nadolol alone in the prophylaxis of the first variceal bleeding in non-ascitic cirrhotic patients ; preliminary results of a multicenter, double blind and randomized trial Hepatology 1997 ; 26 . 135A (abstract).
32. Miyoshi H, Matsumoto A, Oka M, Sugi K, Yoshimura K, Hongou Y, et al. Efficacy or prophylactic sclerotherapy in patients with hepatocellular carcinoma and varices negative for the red color sign. Gastrointest Endosc 1997 ; 45 . 498-502.
33. Lay CS, Tsai YT, Teg CY, Shyu WS, Guo WS, Wu KL, et al. Endoscopic variceal ligation in prophylaxis of first variceal bleeding in cirrhotic patients with high-risk esophageal varices. Hepatology 1997 ; 25 : 1346-50.
34. Sarin S, Lamba G, Kumar M, Mishra A, Murthy N. Randomized trial of propranolol versus endoscopie variceal ligation in the primary prophylaxis of bleeding from high-risk varices in cirrhosis : an interim analysis. Hepatology 1997 ; 26 . 360A (abstract).
35. Teran J, Imperiale T, Mullen K, Tavill A, McCullough A. Primary prophylaxis of variceal bleeding in cirrhosis : a cost-effectiveness analysis. Gastroenterology 1997 ; 112 : 473-82.
36. Bernard B, Leclerc D, Mathurin P, Opolon P, Poynard T. Beta-adrenergic antagonists in the prevention of gastrointestinal rebleeding in patients with cirrhosis : a meta-analysis. Hepatology 1997 ; 25 : 63-70.
37. Bernard B, Lebrec D, Mathurin P, Opolon P, Poynard T. Propranolol and sclerotherapy in the prevention of gastrointestinal rebleeding in patients with cirrhosis : a meta-analysis. J Hepatol 1997 ; 26 : 312-24
38. Baroncini D, Milandri L, Borioni D, Piemontese A, Cennamo V, Billi P, et al. A prospective randomized trial or sclerotherapy versus ligation in the elective treatment of bleeding esophageal varices. Endoscopy 1997 ; 29 : 235-40.
39. Sarin S, Govil A, Jam A, Guptan R, Issar S, Jain M, et al Prospective randomized trial of endoscopic sclerotherapy versus variceal band ligation for esophageal varices : influence on gastropathy, gastric varices and variceal recurrence. J Hepatol 1997 , 26 : 826-32.
40. Avgerinos A, Armonis A, Manolakopoulos S, Poulianos G, Rekoumis G, Sgourou A, et al. Endoscopic sclerotherapy versus variceal ligation in the long term management of patients with cirrhosis after variceal bleeding : a prospective randomized study J Hepatol 1997 ; 26 . 1034-8.
41. Laine L, Stein C, Sharma V. Randomized comparison of ligation versus ligation plus sclerotherapy in patients with bleeding esophageal varices. Gastroenterology 1996 ; 110 : 529-33.
42. Bhargava D, Pakharna R. Endoscopic variceal ligation versus endoscopic variceal ligation and endoscopie sclerotherapy . a prospective randomized study. Am J Gastroenterol 1997 ; 92 : 950-3.
43. Iso Y, Kawanaka H, Tomikawa M, Matsumata T, Kitano S, Sugimachi K. Repeated injection sclerotherapy is preferable to combined therapy with variceal ligation to avoid recurrence of esophageal varices : a prospective randomized trial. Hepatogastroenterol 1997 ; 44 : 467-71.
44. Sarin S. Long-term follow-up of gastric variceal sclerotherapy an eleven-year experience. Gastrointest Endosc 1997 ; 46 : 8-14.
45. Cabrera J, Maynar M, Granados R, Gorriz E, Reyes R, Pulido-Duque J, et al. Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal hemorrhage. Gastroenterology 1996 ; 110 832-9.
46. Cello J, Ring E, Olcott E, Koch J, Gordon R, Sandhu J, et al. Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage : a randomized controlled trial. Ann Intern Med 1997 ; 126 : 858-65.
47. Sanyal A, Freedman A, Luketic V, Purdum P, Shiftman M, Cole P, et al. Transjugular intrahepatic portosystemic shunts compared with endoscopie sclerotherapy for the prevention of recurrent variceal hemorrhage. Ann Intern Med 1997 ; 126 : 849-57.
48. Merli M, Salerno F, Riggio O, De Franchis R, Fiaccadori F, Meddi P, et al. Transjugular intrahepatic portosystemic shunt versus endoscopie sclerotherapy for the prevention of variceal bleeding in cirrhosis : a randomized multicenter trial. Hepatology 1998 , 27 : 40-5.
49. Rössle M, Deibert P, Haag K, Ochs A, Olsclewski M, Siegerstetter V, et al. Randomized trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding. Lancet 1997 ; 349 : 1043-9.
50. Sauer P, Theilmann L, Stremmel W, Benz C, Richter G, Stiehl A. Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus prapranotol for variceal rebleeding. Gastroenterology 1997 , 113 : 1623-31
51. Jalan R, Forrest E, Stanley A, Redhead D, Forbes J, Dillon J, et al. A randomized trial comparing transjugular intrahepatic portosystemic stent shunt with variceal band ligation in the prevention of rebleeding from esophageal varices. Hepatology 1997 , 26 . 1115-22.
52. Sanyal A, Freedman A, Luketic V, Purdum P, Shiffmann M, Demeo J, et al. The natural history or portal hypertension after transjugular intrahepatic portosystemic shunts. Gastroenterology 1997 ; 112 : 889-98
53. Stanley A, Redhead D, Hayes P. Review : update on the role of transjugular intrahepatic portosystemic stent-shunt in the management of complications of portal hypertension. Alim Pharmacol Ther 1997 ; 11 . 261-72.
54. Gschwantler M, Gebauer A, Vavrik J, Madani B, Rohrmoser M, Schrutka Kölbl C, et al. Acute and chronic complications after implantation of a transjugular intrahepatic portosystemic shunt : a prospective study in 53 patients. Z Gastroenterol 1997 ; 35 : 999-1005.
55. Tyburski J, Noorily M, Wilson R. Prognostic factors with the use of the transjugular intrahepatic portosystemic shunt Tor bleeding varices. Arch Sura 1997 ; 132 : 626-31
56. Rosemurgy A, Goode S, Zwiebel B, Black T, Brady P. A prospective trial of transjugular intrahepatic portosystemic stent shunts versus small diameter prosthetic H-graft portacaval shunts in the treatment of Bleeding varices Ann Surg 1997 ; 224 : 378-86.
57. Rosemurgy A, Bloomston M, Zervos E, Goode S, Pencev D, Zwiebel B, et al. Transjugular intrahepatic portosystemic shunts versus H-graft portocaval shunt in the management of bleeding varices : a cost-benefit analysis. Surgery 1997 ; 122 794-800.
58. Gschwantler M, Gebauer A, Rohrmoser M, Schrutka Kölbl C, Vavrik J, Brownstone E, et al. Clinical outcome two years after implantation of a transjugular intrahepatic portosystemic shunt for recurrent variceal bleeding. Eur J Gastroenterol-Hepatol 1997 ; 9 : 15-20.
59. Pommier-Layragues G. TIPS and hepatic encephalopathy Sem Liv Dis 1996 , 16 : 315-20
60. Rössle M The transjugular intrahepatic portosystemic shunt. J Hepatol 1996 ; 25 : 224-31.
61. Zuckerman D, Darcy M, Bocchini T, Hildebot C. Encephalopathy after transjugular intrahepatic portosystemic shunting , analysis of incidence and potential risk factors. Am J Roent 1997 ; 169 : 1727-31.
62. Ducoin H, El-Khoury J, Rousseau H, Barange K, Peron JM, Pierragi MT, et al Histopathologic analysis of transjugular intrahepatic portosystemic shunts. Hepatology 1997 , 25 : 1064-9.